| Popis: |
Well-differentiated thyroid cancer (WDTC) is unique among solid-organ tumours—while its incidence is increasing, its mortality, in the majority of cases, is low. In addition, significant changes have been made in conventional management paradigms, ranging from the initial surgical approach to the increasingly restrictive use of radioactive iodine. The result is that post-surgical management of patients with WDTC is becoming increasingly individualized and based on the risk of recurrence and the morbidity and mortality of WDTC therapies. This chapter reviews this risk-adapted management. |
